Authors:
Bruder, CEG
Hirvela, C
Tapia-Paez, I
Fransson, I
Segraves, R
Hamilton, G
Zhang, XX
Evans, DG
Wallace, AJ
Baser, ME
Zucman-Rossi, J
Hergersberg, M
Boltshauser, E
Papi, L
Rouleau, GA
Poptodorov, G
Jordanova, A
Rask-Andersen, H
Kluwe, L
Mautner, V
Sainio, M
Hung, G
Mathiesen, T
Moller, C
Pulst, SM
Harder, H
Heiberg, A
Honda, M
Miimura, M
Sahlen, S
Blennow, E
Albertson, DG
Pinkel, D
Dumanski, JP
Citation: Ceg. Bruder et al., High resolution deletion analysis of constitutional DNA from neurofibromatosis type 2 (NF2) patients using microarray-CGH, HUM MOL GEN, 10(3), 2001, pp. 271-282
Authors:
Lim, DJ
Rubenstein, AE
Evans, DG
Jacks, T
Seizinger, BG
Baser, ME
Beebe, D
Brackmann, DE
Chiocca, EA
Fehon, RG
Giovannini, M
Glazer, R
Gusella, JF
Gutmann, DH
Korf, B
Lieberman, F
Martuza, R
McClatchey, AI
Parry, DM
Pulst, SM
Ramesh, V
Ramsey, WJ
Ratner, N
Rutkowski, JL
Ruttledge, M
Weinstein, DE
Citation: Dj. Lim et al., Advances in neurofibromatosis 2 (NF2): A workshop report, J NEUROGEN, 14(2), 2000, pp. 63-106
Authors:
Hung, G
Faudoa, R
Baser, ME
Xue, Z
Kluwe, L
Slattery, W
Brackman, D
Lim, D
Citation: G. Hung et al., Neurofibromatosis 2 phenotypes and germ-line NF2 mutations determined by an RNA mismatch method and loss of heterozygosity analysis in NF2 schwannomas, CANC GENET, 118(2), 2000, pp. 167-168
Authors:
Evans, DGR
Newton, V
Neary, W
Baser, ME
Wallace, A
Macleod, R
Jenkins, JPR
Gillespie, J
Ramsden, RT
Citation: Dgr. Evans et al., Use of MRI and audiological tests in presymptomatic diagnosis of type 2 neurofibromatosis (NF2), J MED GENET, 37(12), 2000, pp. 944-947
Authors:
Baser, ME
Birch, PH
Evans, DGR
Friedman, JM
Citation: Me. Baser et al., Association of superficial plexiform and paraspinal neurofibromas in neurofibromatosis 1 (NF1), NEUROLOGY, 52(7), 1999, pp. 1519-1520
Citation: Me. Baser et al., Germ-line NF2 mutations and disease severity in neurofibromatosis type 2 patients with retinal abnormalities, AM J HU GEN, 64(4), 1999, pp. 1230-1233